Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet E Pope

Showing results (51-60 of 299) with videos related to

Pageof 30
Sort By:
Clinical and Experimental Rheumatology|October 1, 2021
The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritisAndrew E Thompson, Janet E Pope
Annals of the Rheumatic Diseases|January 7, 2023
Jack pot! What can we learn about registries with respect to treatment cycling in rheumatoid arthritis?Janet E Pope, Roy M Fleischmann
Drugs|December 15, 2015
Diagnosis and Management of Systemic Sclerosis: A Practical ApproachJason J Lee, Janet E Pope
Best Practice & Research. Clinical Rheumatology|April 7, 2026
Renal involvement in systemic sclerosisIbraheem M Almani, Janet E Pope
Current Opinion in Rheumatology|January 22, 2021
Scleroderma epidemiology updateLeonardo Martin Calderon, Janet E Pope
The Journal of Rheumatology|September 18, 2002
Increased prevalence of scleroderma in southwestern Ontario: a cluster analysisAndrew E Thompson, Janet E Pope
Expert Opinion on Emerging Drugs|November 5, 2016
Emerging drugs and therapeutics for systemic sclerosisJason J Lee, Janet E Pope
The Lancet. Rheumatology|January 26, 2024
European consensus statements for interstitial lung disease in systemic sclerosisAndreu Fernández-Codina, Janet E Pope
Rheumatic Diseases Clinics of North America|April 7, 2018
Randomized Trials, Meta-Analyses, and Systematic Reviews: Using Examples from RheumatologyJanet E Pope, Glen S Hazlewood
Arthritis Research & Therapy|September 26, 2014
A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseasesJason J Lee, Janet E Pope
Pageof 30

Showing results (51-60 of 299) with videos related to

Sort By:
Pageof 30
Clinical and Experimental Rheumatology|October 1, 2021
The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritisAndrew E Thompson, Janet E Pope
Annals of the Rheumatic Diseases|January 7, 2023
Jack pot! What can we learn about registries with respect to treatment cycling in rheumatoid arthritis?Janet E Pope, Roy M Fleischmann
Drugs|December 15, 2015
Diagnosis and Management of Systemic Sclerosis: A Practical ApproachJason J Lee, Janet E Pope
Best Practice & Research. Clinical Rheumatology|April 7, 2026
Renal involvement in systemic sclerosisIbraheem M Almani, Janet E Pope
Current Opinion in Rheumatology|January 22, 2021
Scleroderma epidemiology updateLeonardo Martin Calderon, Janet E Pope
The Journal of Rheumatology|September 18, 2002
Increased prevalence of scleroderma in southwestern Ontario: a cluster analysisAndrew E Thompson, Janet E Pope
Expert Opinion on Emerging Drugs|November 5, 2016
Emerging drugs and therapeutics for systemic sclerosisJason J Lee, Janet E Pope
The Lancet. Rheumatology|January 26, 2024
European consensus statements for interstitial lung disease in systemic sclerosisAndreu Fernández-Codina, Janet E Pope
Rheumatic Diseases Clinics of North America|April 7, 2018
Randomized Trials, Meta-Analyses, and Systematic Reviews: Using Examples from RheumatologyJanet E Pope, Glen S Hazlewood
Arthritis Research & Therapy|September 26, 2014
A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseasesJason J Lee, Janet E Pope
Pageof 30